Tarsus Pharmaceuticals, Inc. TARS Operating Lease Liability Payments - Thereafter (Lessee)
Operating Lease Liability Payments - Thereafter (Lessee) at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-K, filed February 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s operating lease liability payments - thereafter (lessee).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s operating lease liability payments - thereafter (lessee)?
- Tarsus Pharmaceuticals, Inc. (TARS) reported operating lease liability payments - thereafter (lessee) of $15.4M in Q4 2025.